A Retrospective Study to Investigate the Efficacy and Relative Factors of Ocular Acupuncture in Ocular Motor Nerve Palsy Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Oculomotor Nerve Palsy
- Sponsor
- First Affiliated Hospital of Harbin Medical University
- Enrollment
- 900
- Primary Endpoint
- Clinical efficacy rate (Cure, Effective and Invalid)
- Last Updated
- 8 years ago
Overview
Brief Summary
This retrospective observational study is designed to assess the response to treatment with ocular acupuncture and its relative factors, in terms of diplopia status, ocular motility differences, and clinical features, in ocular motor nerve palsy patients. During this study, a retrospective data collection will be carried out using the information contained in the medical record of aimed patients, provided that the treatment with ocular acupuncture.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age over 18 years old
- •Patient who received at lease 1 times of ocular acupuncture treatment
- •Patient who received full set of ophthalmology \& neurology assessment pre- and post-treatment.
Exclusion Criteria
- •patient who combined with extraocular muscles diseases, eg.thyroid eye disease
- •patient who underwent periocular surgery
- •patient who combined with congenital ocular motor nerve palsy, eg. Brown syndrome.
- •patient who had untreated condition which may lead to ocular motor nerve palsy such as intracranial aneurysm and brain tumor.
Outcomes
Primary Outcomes
Clinical efficacy rate (Cure, Effective and Invalid)
Time Frame: Through study completion, an average of 1 month.
Clinical efficacy rate (Cure, Effective and Invalid) assessed by investigator's discretion. Efficacy rate is calculated as number of patients with Cure and effective proportional to number of all cases.
Secondary Outcomes
- Diplopia angle(Through study completion, an average of 2 weeks.)
- Eyeball movement distance(Through study completion, an average of 2 weeks.)
- Distance between upper and lower eyelid.(Through study completion, an average of 2 weeks.)